EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma

Gastrointestinal Endoscopy

Volumn 67, Issue 3, 2008, Pages 438-443

  Gleeson, Ferga C ^a   Rajan, Elizabeth ^a   Levy, Michael J ^a   Clain, Jonathan E ^a   Topazian, Mark D ^a   Harewood, Gavin C ^a   Papachristou, Georgios I ^a   Takahashi, Naoki ^a   Rosen, Charles B ^a   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASPIRATION BIOPSY; BILE DUCT CARCINOMA; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOLOGY; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LAPAROTOMY; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRIORITY JOURNAL;

ADULT; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOPSY, FINE-NEEDLE; CHOLANGIOCARCINOMA; COHORT STUDIES; ENDOSONOGRAPHY; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURGERY, COMPUTER-ASSISTED;

EID: 39149111656     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2007.07.018     Document Type: Article

References (25)

1. Shaib Y.H., El-Serag H.B., Davila J.A., et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128 (2005) 620-626
2. Nakeeb A., Pitt H.A., Sohn T.A., et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224 (1996) 463-473 discussion 473-5
3. Rea D.J., Munoz Juarez M., Farnell M.B., et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 139 (2004) 514-523 discussion 523-5
4. Ortner M.A., Liebetruth J., Schreiber S., et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 114 (1998) 536-542
5. Chen V.K., and Eloubeidi M.A. Endoscopic ultrasound-guided fine needle aspiration is superior to lymph node echofeatures: a prospective evaluation of mediastinal and peri-intestinal lymphadenopathy. [review]. Am J Gastroenterol 99 (2004) 628-633
6. Tanaka N., Yamakado K., Nakatsuka A., et al. Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma: initial experience. Eur J Radiol 41 (2002) 42-48
7. Rea D.J., Heimbach J.K., Rosen C.B., et al. Liver transplantation with neoadjuvent chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242 (2005) 451-458
8. Lazaridis K.M., and Gores G.J. Cholangiocarcinoma. Gastroenterology 128 (2005) 1655-1667
9. Bellamy C.O., DiMartini A.M., Ruppert K., et al. Liver transplantation for alcoholic cirrhosis: long-term follow-up and impact of disease recurrence. Transplantation 72 (2001) 619-626
10. Rosen C.B., Heimbach J.K., Haddock M.G., et al. Liver transplantation with neoadjuvant chemoradiotherapy for hilar cholangiocarcinoma. [abstract]. Am J Transplant 4 Suppl 8 (2004) 436
11. Catalano M.F., Sivak M.V., Rice T., et al. Endosonographic features predictive of lymph node metastases. Gastrointest Endosc 40 (1994) 442-446
12. American Joint Committee on Cancer. AJCC Cancer staging manual, 6th ed. Springer: Chicago; 2002.
13. Faigel D.O. EUS in patients with benign and malignant lymphadenopathy. Gastrointest Endosc 53 (2001) 593-598
14. Nakagawa T., Kamiyama T., Kurauchi N., et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 29 (2005) 728-733
15. Pulhalla H., Gruenberger T., Pokorny H., et al. Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis. World J Surg 27 (2003) 680-684
16. Uenishi T., Hirohashi K., Kubo S., et al. Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma. World J Surg 25 (2001) 865-869
17. Yamamoto M., Takasaki K., and Yoshikawa T. Lymph node metastases in intrahepatic cholangiocarcinoma. Jpn J Clin Oncol 29 (1999) 147-150
18. Morimoto Y., Tanaka Y., Ito T., et al. Long-term and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10 (2003) 432-440
19. Boberg K.M., Bergquist A., Mitchell S., et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 37 (2002) 1205-1211
20. Kaczynski J., Hansson G., Wallerstedt S., et al. Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma: a study of 51 cases from a low-endemicity area. Acta Oncol 37 (1998) 77-83
21. Kitagawa Y., Nagino M., Kamiya J., et al. Lymph node metastases from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic dissection. Ann Surg 233 (2001) 385-392
22. Valls C., Guma A., Puig I., et al. Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25 (2000) 490-496
23. Lee H.Y., Kim S.H., Lee J.M., et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239 (2006) 113-121
24. Hanninen E.L., Pech M., Jonas S., et al. Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol 46 (2005) 462-470
25. Petrowsky H., Wildbrett P., Husarik D.B., et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 45 (2006) 43-50